Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Study: Coffee reduces risk for prostate cancer

Jan. 11 (UPI) — Drinking several cups of coffee daily appears to lower risk for developing prostate cancer, according to an... Read More

Study: Smell Receptors Help Progress of Prostate Cancer

A cell receptor responsible for the sense of smell plays a critical role in prostate cancer progression, according to a... Read More

Radiation, Hormone Therapy Combo Best Against Aggressive Prostate Cancer: Study

High doses of radiotherapy and hormonal therapy offer the best chance for decreasing death risk in men with aggressive prostate... Read More

Scientists Develop New Immunotherapy for Prostate Cancer

Researchers at The Wistar Institute have created a new immunotherapy technology to treat prostate cancer using synthetic DNA against a... Read More

Prostate Cancer Screening Should Start Earlier for Black Men, Researchers Say

Incidence of prostate cancer is 60 percent higher among black men in the United States than among white men, said... Read More

New Combination Treatment for Prostate Cancer Shows Promise

New combination therapy identified that may do more than just extend survival but could cure metastatic prostate cancer. A pilot... Read More

Drinking Alcohol May Increase Risk for Prostate Cancer

Drinking may raise the risk of prostate cancer, and the more men drink the greater their risk, a new analysis... Read More

Study: Drug Sensitises to Radiation, Reduces Spread of Prostate Cancer

Research conducted by Johns Hopkins Medicine suggests an experimental drug targeting abnormally high levels of a protein linked to cancer... Read More